We would love to hear from you. Click on the ‘Contact Us’ link to the right and choose your favorite way to reach-out!

wscdsdc

media/speaking contact

Jamie Johnson

business contact

Victoria Peterson

Contact Us

855.ask.wink

Close [x]
pattern

Industry News

Categories

  • Industry Articles (21,155)
  • Industry Conferences (2)
  • Industry Job Openings (35)
  • Moore on the Market (414)
  • Negative Media (144)
  • Positive Media (73)
  • Sheryl's Articles (800)
  • Wink's Articles (353)
  • Wink's Inside Story (274)
  • Wink's Press Releases (123)
  • Blog Archives

  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • August 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • November 2008
  • September 2008
  • May 2008
  • February 2008
  • August 2006
  • Analysts say it's unlikely Aviva can sell its U.S. division

    April 24, 2012 by Adam Belz

    11:44 PM, Apr. 23, 2012  |  

    Written by

    ADAM BELZ

    Aviva may want to sell its U.S. business, but the real question may be whether anyone wants to buy it.

    Analysts say it’s unlikely the British insurer Aviva PLC can sell its U.S. division — headquartered at a $140 million campus in West Des Moines where roughly 1,300 people work — for anywhere near the price it would like.

    Rumors have swirled through the financial press since Aviva’s global CEO, Andrew Moss, told investors privately two weeks ago he would consider offers on the U.S. business. One British newspaper, the Times of London, has gone so far as to put a date on an announcement of the sale: May 24.

    But analysts say the reasons Aviva may want to sell are the same reasons it would be difficult to do so. Aviva paid about $3.2 billion in today’s dollars for AmerUs in 2006, but the business has lost value, the U.S. indexed annuities market as a whole was flat in 2011, and an impending set of European insurance regulations casts doubt on the future of trans-Atlantic insurance companies.

    “The speculation is that the group may only get 1 billion pounds ($1.6 billion) if it was sold today,” Eamonn Flanagan, an analyst with Shore Capital in Chester, England, told the Register in an email. “Although a ($1.6 billion) exit price would ‘hurt’ Aviva, I think they would probably accept it, as a sale would free up a considerable amount of capital for the group, which it could utilize elsewhere in the business.”

    Barrie Cornes, an analyst at Panmure Gordon, an investment bank in England, takes a different view. He believes Aviva has wanted to sell its U.S. business for two years, but he doesn’t think Aviva is desperate enough to sell for the price the company could fetch today.

    “It’s possible, but I think it would be disappointing if they did and only got the rumored ($1.6 billion),” he wrote in an email to the Register.

    Officials at Aviva have been silent on the possibility of the sale, and the past two weeks have been busy ones for the company. Three top executives, including Richard Hoskins, CEO of the company’s North American operations, stepped down last week. Aviva USA CEO Chris Littlefield will now report directly to Moss instead of Hoskins.

    A spokesman for Aviva USA said the change will have no impact in West Des Moines, and Littlefield wrote a letter to agents addressing the sale rumors as soon as they became public.

    “Obviously things can change and CEOs have an obligation to consider offers that make sense for the company’s shareholders,” Littlefield wrote. “However, if there is ever a decision to sell the U.S. business, you will hear it from us directly rather than just read about it in the paper.”

    Aviva traffics mainly in indexed annuities — a safe, low-return investment product that’s popular with risk-averse retirees and baby boomers. Generally customers turn over money to Aviva — often a portion of their retirement savings — and Aviva gives it back to them in a stream of payments over the rest of their lives.

    With indexed annuities, Aviva guarantees the customer won’t lose money on the investment. The rate of return is tied to a market index like the S&P, but won’t rise above a certain percentage, and won’t go negative. That makes the product different from variable annuities, which function like mutual funds, offering higher potential returns but also the possibility of a loss.

    According to Annuity-Specs.com, an industry data firm in Pleasant Hill, Aviva was the No. 2 seller of indexed annuities in the U.S. in 2011, with $4.5 billion in sales. But that was a 13.5 percent decline from 2010. Meanwhile, competitor American Equity Investment Life, also in West Des Moines, saw sales rise by 6.4 percent, to $4.4 billion, according to AnnuitySpecs.

    Aviva cited low interest rates for its sales decline. Low interest rates make it harder to earn money selling annuities, since profit comes from the difference between the interest paid to the customer and the interest earned by the insurer through investing the money.

    “In light of the low interest rate environment, we have been intentionally balancing volume with profitability on our annuity business,” Kevin Waetke, Aviva USA spokesman, said in a statement. “We still have a large and significant annuities business, our total book of annuities business continues to grow and we are committed to continuing to strengthen our leading annuity franchise.”

    Indexed annuities command about 14 percent of the annuity market, but they’ve gained market share since 2007. They’re safe, so investors turn to them when markets are down. When the stock market rises, variable annuities become more popular.

    Cornes said Aviva has pulled back from selling indexed annuities because of the capital requirements. Because the risk of losses is borne by the insurer, regulators require insurers to carry high levels of capital as a cushion against losses. Not so for variable annuities, which place the risk of a market crash on the shoulders of customers unless they buy expensive riders to protect themselves.

    This makes the prospect of a new, more rigorous set of capital requirements in Europe, known as Solvency II, even more troublesome for Aviva than it is for firms that sell mostly variable annuities –— say Prudential, and its subsidiary Jackson Life.

    Solvency II could go into effect as early as Jan. 1, 2013. The details are not settled, but the uncertainty has forced European companies to consider unloading American subsidiaries. Prudential, also based in England, has threatened to move its headquarters to the U.S. or Asia if the firm doesn’t like how the rules shake out.

    Cornes said selling the U.S. business makes sense for Aviva. Aviva plc’s European business could use the capital boost, the move would erase some uncertainty around Solvency II, and Aviva should focus on its European business anyway, he said. But he doesn’t think Aviva can get the price it wants.

    “Whilst there may be a strong rationale for such a sale including the consequent capital boost, Solvency II concerns, and the European strategic focus, we do not think that current prices for U.S. life businesses make a disposal sensible at the current time,” Cornes wrote.

    Until Solvency II is resolved, the pool of potential buyers for Aviva’s U.S. business would probably be limited to large American insurers, such as MetLife or New York Life, Flanagan said.

    “A UK or European buyer would face the same problems that Aviva has — namely capital intensity and a changing regulatory regime,” Flanagan said. “A U.S. company may find it easier to launch its own product range.”

    Originally Posted at The Des Moines Register on April 23, 2012 by Adam Belz.

    Categories: Sheryl's Articles
    currency